Diabetes Disease

L.Vijaab, et al.

Mesenchymal stem cells are multipotent non-haematopoietic progenitor cells that are being explored as a promising new treatment for tissue regeneration.

Reza Abdi, et al.

Mesenchymal stem cells (MSCs) are pluripotent stromal cells that have the potential to give rise to cells of diverse lineages. Interestingly

Vineet Kumar Mishra, et al.

The pleiotropic behavior of mesenchymal stem cells (MSCs) has gained global attention due to their immense potential for immunosuppression

Mairim Alexandra Solis, et al.

Latin America is a fast-growing region that currently faces unique challenges in the treatment of all forms of diabetes mellitus.

Mohamed M. Kamal, et al.

Diabetes mellitus (DM) is an alarming metabolic disease in which insulin secreting β-cells are damaged to various extent.

Alvaro Moreira, et al.

Mesenchymal stem cells are self-renewing multipotent cells that have the capacity to secrete multiple biologic factors that can restore and repair tissues.

Anupama Kakkar, et al.

Diabetes mellitus is a major health concern in current scenario which has been found to affect people of almost all ages. The disease has huge impact

Hiroyuki Takahashi et al.

Type 1 diabetes mellitus (T1DM) is caused by the autoimmune targeting of pancreatic β-cells, and, in the advanced stage, severe hypoinsulinemia..

Yicheng Qi, Jing Ma, Shengxian Li, and Wei Liu

Type 2 diabetes mellitus (T2DM) is mainly characterized by insulin resistance (IR) and impaired insulin secretion.

Nadine E. Rekittke et al.

Type 1 diabetes is an autoimmune disease resulting in the permanent destruction of pancreatic islets.

Jingjing He et al.

Diabetes mellitus as a chronic metabolic disease is threatening human health seriously. Although numerous clinical trials have been registered

Arianna Scuteri and Marianna Monfrini

Diabetes is a worldwide disease which actually includes different disorders related to glucose metabolism. According to different epidemiological studies,

Wei Zhang

Both UC-MSCs and BM-MSCs exhibited comparable therapeutic effects on improving glycaemic control and preserving β-cell function in T1D.